Clinical trial
Safety of Bryostatin in Patients With MS
NCT06190912
Study timeline
Study start (actual)2024-06-26Date precision: day
Registry last updated2026-03-31
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Multiple Sclerosisunresolved
Interventions
Bryostatin 1DRUG
Sponsors & collaborators
Robert Foxlead sponsor
Synaptogenix, Inc.collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06190912 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.